Nuvasive reported $10.75M in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 1342M 767M
Abiomed ABMD:US $ 62.8M 8.55M
Atricure ATRC:US $ -15.88M 1.62M
Baxter International BAX:US $ 424M 34M
Becton, Dickinson and BDX:US $ 414M 816M
Boston Scientific BSX:US $ 262M 108M
Cardiovascular Systems CSII:US $ -5.65M 5.93M
Cooper Companies COO:US $ 143.2M 9.8M
Dexcom DXCM:US $ 101M 55.1M
Edwards Lifesciences EW:US $ 542.1M 158.6M
Globus Medical GMED:US $ 54.55M 3.99M
Haemonetics HAE:US $ -21.18M 61.6M
Hill Rom HRC:US $ 79.6M 34.7M
Hologic HOLX:US $ 358.6M 438.2M
Inogen INGN:US $ -2132000 3.39M
Insulet PODD:US $ 16.3M 23.6M
Integra Lifesciences IART:US $ 51.85M 19.55M
Intuitive Surgical ISRG:US $ 511.2M 94.4M
Johnson & Johnson JNJ:US $ 6662M 767M
Medtronic MDT:US $ 1607M 330M
Merit Medical Systems MMSI:US $ 8.9M 5.3M
Nuvasive NUVA:US $ 10.75M 1.59M
Stryker SYK:US $ 729M 259M
Tandem Diabetes Care TNDM:US $ -3.24M 21.9M
Teleflex TFX:US $ 115.63M 12.2M
Zimmer Biomet Holdings Inc ZBH:US $ 265.6M 24.9M